http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27193617

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, U.S. Gov't, P.H.S.
endingPage 766
issn 0027-8874
1460-2105
issueIdentifier 11
pageRange 757-766
publicationName JNCI Journal of the National Cancer Institute
startingPage 757
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be685b7ad631dad5c348ceaff36a807c
bibliographicCitation Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. JNCI Journal of the National Cancer Institute. 1991 Jun 05;83(11):757–66. doi: 10.1093/jnci/83.11.757.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_584911eb1f63e493dae5850631e30269
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_706b000adac64d861f0516285f687648
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7c4331b31d5b82b4e16a2853d4457e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e85903ac0834ca23bc98333d45b17bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4eaf54f85320f55568c97fcb4764753
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e58fd71bfa09356670616df600021384
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8fd3368057073f7ec4945e0b68e152f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_003c0b8b2b8ffc985c2131ae7f3c1631
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9b0e347a76ce739ec75a6907e9f13fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7e84b44fb673b6cbf81f590a388795b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc18465ec04368c56beb1e429dbe34c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29145b026b980a5600b9ecf1cc3a9943
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3941f727c09300b3ec332ea1fee66e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e363bbc83bd1c478a9288a3413ed97dd
date 1991-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1093/jnci/83.11.757
https://pubmed.ncbi.nlm.nih.gov/2041050
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4982
https://portal.issn.org/resource/ISSN/1460-2105
https://portal.issn.org/resource/ISSN/0027-8874
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D004354Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011786
http://id.nlm.nih.gov/mesh/D014407Q000187
http://id.nlm.nih.gov/mesh/D002455Q000187
http://id.nlm.nih.gov/mesh/D002470Q000187
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65191
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4301922
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448

Total number of triples: 46.